Given that the m6A modification is primarily catalyzed by methyltransferase (writers) and demethylase (erasers), we hypothesized that the abnormal m6A modification in CHD was caused by the dysregulation of m6A writers and erasers. The gene discussed is MBD2; the disease is coronary artery disorder.